These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 32805515)
1. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine. Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515 [TBL] [Abstract][Full Text] [Related]
2. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723 [TBL] [Abstract][Full Text] [Related]
3. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis. Tomita Y; Sato R; Ikeda T; Sakagami T Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070 [TBL] [Abstract][Full Text] [Related]
4. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark. Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115 [TBL] [Abstract][Full Text] [Related]
5. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Charoenlap S; Piromsopa K; Charoenlap C Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943 [TBL] [Abstract][Full Text] [Related]
6. Is BCG vaccination affecting the spread and severity of COVID-19? Ozdemir C; Kucuksezer UC; Tamay ZU Allergy; 2020 Jul; 75(7):1824-1827. PubMed ID: 32330314 [No Abstract] [Full Text] [Related]
7. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2? Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM Front Immunol; 2020; 11():970. PubMed ID: 32574258 [TBL] [Abstract][Full Text] [Related]
8. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity. Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931 [TBL] [Abstract][Full Text] [Related]
9. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Hachim A; Kavian N; Cohen CA; Chin AWH; Chu DKW; Mok CKP; Tsang OTY; Yeung YC; Perera RAPM; Poon LLM; Peiris JSM; Valkenburg SA Nat Immunol; 2020 Oct; 21(10):1293-1301. PubMed ID: 32807944 [TBL] [Abstract][Full Text] [Related]
10. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives. Gruer L; Bhopal R BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002 [No Abstract] [Full Text] [Related]
11. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS. Fierz W; Walz B Front Immunol; 2020; 11():1120. PubMed ID: 32582200 [TBL] [Abstract][Full Text] [Related]
12. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak. Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308 [TBL] [Abstract][Full Text] [Related]
13. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward. Bryant JE; Azman AS; Ferrari MJ; Arnold BF; Boni MF; Boum Y; Hayford K; Luquero FJ; Mina MJ; Rodriguez-Barraquer I; Wu JT; Wade D; Vernet G; Leung DT Sci Immunol; 2020 May; 5(47):. PubMed ID: 32430309 [TBL] [Abstract][Full Text] [Related]
14. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies. Goetz L; Yang J; Greene W; Zhu Y J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181 [No Abstract] [Full Text] [Related]
15. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380 [TBL] [Abstract][Full Text] [Related]
16. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic? Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224 [TBL] [Abstract][Full Text] [Related]
17. Impact of Routine Infant BCG Vaccination on COVID-19. Kinoshita M; Tanaka M J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481 [TBL] [Abstract][Full Text] [Related]
18. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now). Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947 [TBL] [Abstract][Full Text] [Related]
19. BCG-induced trained immunity: can it offer protection against COVID-19? O'Neill LAJ; Netea MG Nat Rev Immunol; 2020 Jun; 20(6):335-337. PubMed ID: 32393823 [TBL] [Abstract][Full Text] [Related]
20. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends". Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG Front Immunol; 2020; 11():2059. PubMed ID: 33013871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]